﻿<?xml version="1.0" encoding="utf-8"?>
<Return xmlns="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.irs.gov/efile" returnVersion="2023v5.1">
  <ReturnHeader binaryAttachmentCnt="0">
    <ReturnTs>2024-11-06T18:03:26-06:00</ReturnTs>
    <TaxPeriodEndDt>2023-12-31</TaxPeriodEndDt>
    <PreparerFirmGrp>
      <PreparerFirmEIN>946214841</PreparerFirmEIN>
      <PreparerFirmName>
        <BusinessNameLine1Txt>ARMANINO ADVISORY LLC</BusinessNameLine1Txt>
      </PreparerFirmName>
      <PreparerUSAddress>
        <AddressLine1Txt>21650 OXNARD STREET STE 2400</AddressLine1Txt>
        <CityNm>WOODLAND HILLS</CityNm>
        <StateAbbreviationCd>CA</StateAbbreviationCd>
        <ZIPCd>91367</ZIPCd>
      </PreparerUSAddress>
    </PreparerFirmGrp>
    <ReturnTypeCd>990</ReturnTypeCd>
    <TaxPeriodBeginDt>2023-01-01</TaxPeriodBeginDt>
    <Filer>
      <EIN>954450030</EIN>
      <BusinessName>
        <BusinessNameLine1Txt>NATIONAL INSTITUTE OF TRANSPLANTATION</BusinessNameLine1Txt>
        <BusinessNameLine2Txt>FOUNDATION</BusinessNameLine2Txt>
      </BusinessName>
      <BusinessNameControlTxt>NATI</BusinessNameControlTxt>
      <PhoneNum>4243584450</PhoneNum>
      <USAddress>
        <AddressLine1Txt>2600 WEST OLIVE AVE 500</AddressLine1Txt>
        <CityNm>BURBANK</CityNm>
        <StateAbbreviationCd>CA</StateAbbreviationCd>
        <ZIPCd>91505</ZIPCd>
      </USAddress>
    </Filer>
    <BusinessOfficerGrp>
      <PersonNm>NICOLE MENDEZ-YZAGUIRRE</PersonNm>
      <PersonTitleTxt>EXECUTIVE DIRECTOR</PersonTitleTxt>
      <PhoneNum>4243584450</PhoneNum>
      <SignatureDt>2024-11-06</SignatureDt>
      <DiscussWithPaidPreparerInd>1</DiscussWithPaidPreparerInd>
    </BusinessOfficerGrp>
    <IRSResponsiblePrtyInfoCurrInd>1</IRSResponsiblePrtyInfoCurrInd>
    <PreparerPersonGrp>
      <PreparerPersonNm>MATTHEW PETROSKI</PreparerPersonNm>
      <PTIN>P00853132</PTIN>
      <PhoneNum>8185879300</PhoneNum>
      <PreparationDt>2024-11-06</PreparationDt>
    </PreparerPersonGrp>
    <TaxYr>2023</TaxYr>
    <BuildTS>2024-10-15 13:58:12Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCnt="9">
    <IRS990 documentId="RetDoc1038000001" referenceDocumentId="RetDoc1044400001">
      <PrincipalOfficerNm>NICOLE MENDEZ-YZAGUIRRE</PrincipalOfficerNm>
      <USAddress>
        <AddressLine1Txt>2600 WEST OLIVE AVE 500</AddressLine1Txt>
        <CityNm>BURBANK</CityNm>
        <StateAbbreviationCd>CA</StateAbbreviationCd>
        <ZIPCd>91505</ZIPCd>
      </USAddress>
      <GrossReceiptsAmt>2277227</GrossReceiptsAmt>
      <GroupReturnForAffiliatesInd>0</GroupReturnForAffiliatesInd>
      <Organization501c3Ind>X</Organization501c3Ind>
      <WebsiteAddressTxt>WWW.MNITF.ORG</WebsiteAddressTxt>
      <TypeOfOrganizationCorpInd>X</TypeOfOrganizationCorpInd>
      <FormationYr>1985</FormationYr>
      <LegalDomicileStateCd>CA</LegalDomicileStateCd>
      <ActivityOrMissionDesc>THE FOUNDATION'S PRIMARY PURPOSE IS TO ADVANCE THE SCIENCE AND PRACTICE OF ORGAN TRANSPLANTATION THROUGH EDUCATION AND RESEARCH PROGRAMS.</ActivityOrMissionDesc>
      <VotingMembersGoverningBodyCnt>7</VotingMembersGoverningBodyCnt>
      <VotingMembersIndependentCnt>6</VotingMembersIndependentCnt>
      <TotalEmployeeCnt>2</TotalEmployeeCnt>
      <TotalVolunteersCnt>20</TotalVolunteersCnt>
      <TotalGrossUBIAmt>0</TotalGrossUBIAmt>
      <NetUnrelatedBusTxblIncmAmt>0</NetUnrelatedBusTxblIncmAmt>
      <PYContributionsGrantsAmt>221640</PYContributionsGrantsAmt>
      <CYContributionsGrantsAmt>268831</CYContributionsGrantsAmt>
      <PYProgramServiceRevenueAmt>0</PYProgramServiceRevenueAmt>
      <CYProgramServiceRevenueAmt>0</CYProgramServiceRevenueAmt>
      <PYInvestmentIncomeAmt>1003014</PYInvestmentIncomeAmt>
      <CYInvestmentIncomeAmt>387772</CYInvestmentIncomeAmt>
      <PYOtherRevenueAmt>-7715</PYOtherRevenueAmt>
      <CYOtherRevenueAmt>-364703</CYOtherRevenueAmt>
      <PYTotalRevenueAmt>1216939</PYTotalRevenueAmt>
      <CYTotalRevenueAmt>291900</CYTotalRevenueAmt>
      <PYGrantsAndSimilarPaidAmt>474860</PYGrantsAndSimilarPaidAmt>
      <CYGrantsAndSimilarPaidAmt>414513</CYGrantsAndSimilarPaidAmt>
      <PYBenefitsPaidToMembersAmt>0</PYBenefitsPaidToMembersAmt>
      <CYBenefitsPaidToMembersAmt>0</CYBenefitsPaidToMembersAmt>
      <PYSalariesCompEmpBnftPaidAmt>256811</PYSalariesCompEmpBnftPaidAmt>
      <CYSalariesCompEmpBnftPaidAmt>270034</CYSalariesCompEmpBnftPaidAmt>
      <PYTotalProfFndrsngExpnsAmt>0</PYTotalProfFndrsngExpnsAmt>
      <CYTotalProfFndrsngExpnsAmt>0</CYTotalProfFndrsngExpnsAmt>
      <CYTotalFundraisingExpenseAmt>65712</CYTotalFundraisingExpenseAmt>
      <PYOtherExpensesAmt>1895989</PYOtherExpensesAmt>
      <CYOtherExpensesAmt>330917</CYOtherExpensesAmt>
      <PYTotalExpensesAmt>2627660</PYTotalExpensesAmt>
      <CYTotalExpensesAmt>1015464</CYTotalExpensesAmt>
      <PYRevenuesLessExpensesAmt>-1410721</PYRevenuesLessExpensesAmt>
      <CYRevenuesLessExpensesAmt>-723564</CYRevenuesLessExpensesAmt>
      <TotalAssetsBOYAmt>16447929</TotalAssetsBOYAmt>
      <TotalAssetsEOYAmt>17579203</TotalAssetsEOYAmt>
      <TotalLiabilitiesBOYAmt>416786</TotalLiabilitiesBOYAmt>
      <TotalLiabilitiesEOYAmt>507706</TotalLiabilitiesEOYAmt>
      <NetAssetsOrFundBalancesBOYAmt>16031143</NetAssetsOrFundBalancesBOYAmt>
      <NetAssetsOrFundBalancesEOYAmt>17071497</NetAssetsOrFundBalancesEOYAmt>
      <InfoInScheduleOPartIIIInd>X</InfoInScheduleOPartIIIInd>
      <MissionDesc>THE FOUNDATION'S PRIMARY PURPOSE IS TO ADVANCE THE SCIENCE AND PRACTICE OF ORGAN TRANSPLANTATION THROUGH EDUCATION AND RESEARCH PROGRAMS.</MissionDesc>
      <SignificantNewProgramSrvcInd>1</SignificantNewProgramSrvcInd>
      <SignificantChangeInd>0</SignificantChangeInd>
      <ExpenseAmt>414513</ExpenseAmt>
      <GrantAmt>414513</GrantAmt>
      <Desc>THE NITF AWARDS RESEARCH GRANTS SEMIANNUALLY TO IMPROVE CLINICAL OUTCOMES AND POSITIVELY IMPACT THE FIELD OF TRANSPLANTATION. IN 2023, NITF AWARDED 3 GRANTS TOTALING $414,513.</Desc>
      <ProgSrvcAccomActy2Grp>
        <ExpenseAmt>23285</ExpenseAmt>
        <Desc>EDUCATION - LINKED BY LOVE SERIES:IN 2022, WE PRODUCED THE LINKED BY LOVE SERIES AND ALL KIDNEYS ARE PINK DOCUSERIES. WE COMPLETED PRODUCTION AND RELEASED IN MARCH 2023. THIS SERIES IS ON YOUTUBE AND LINKED BY LOVE WEBSITE. THIS SERIES IS THE NEWEST ADDITION TO OUR LIBRARY OF DIGITAL "EDUTAINMENT" TO PROVIDE VITAL HEALTHCARE INFORMATION ABOUT KIDNEY DISEASE, KIDNEY TRANSPLANTATION AND LIVING DONATION TO AT-RISK POPULATIONS, PRIMARILY BLACK AND LATINO. LINKED BY LOVE IS AN EFFORT TO DECREASE THE DISPARITIES OF KIDNEY DISEASE AND INCREASE ACCESS OF KIDNEY TRANSPLANTATION AMONG THE BLACK POPULATION. THERE WERE OVER 21,000 VISITORS.</Desc>
      </ProgSrvcAccomActy2Grp>
      <ProgSrvcAccomActy3Grp>
        <ExpenseAmt>197135</ExpenseAmt>
        <Desc>EDUCATION - BROADCAST AND SOCIAL MEDIA CAMPAIGNS:IN 2023, NITF RELEASED THE LINKED BY LOVE PSA ON TV AND RADIO TO INCREASE AWARENESS ABOUT KIDNEY DISEASE AND FAILURE, TRANSPLANTATION AND LIVING DONATION. THERE WAS ABOUT 205,500,000 IMPRESSIONS (TRACKED FROM FEB. THROUGH JULY 2023). THE SOCIAL MEDIA CAMPAIGN PROVIDED KIDNEY DISEASE PREVENTION,HEALTHY LIVING, KIDNEY TRANSPLANT AND LIVING DONATION INFORMATION BY POSTING ON FACEBOOK, INSTAGRAM AND TIKTOK. THERE WERE OVER 1,190,000 IMPRESSIONS. BOTH CAMPAIGNS TARGETED THE BLACK AND HISPANIC POPULATIONS, WHO ARE MOST AT-RISK OF KIDNEY DISEASE AND FAILURE IN AN EFFORT TO DECREASE THE DISPARITIES.</Desc>
      </ProgSrvcAccomActy3Grp>
      <TotalProgramServiceExpensesAmt>634933</TotalProgramServiceExpensesAmt>
      <DescribedInSection501c3Ind referenceDocumentId="RetDoc1039100001">1</DescribedInSection501c3Ind>
      <ScheduleBRequiredInd referenceDocumentId="RetDoc1234500001">1</ScheduleBRequiredInd>
      <PoliticalCampaignActyInd>0</PoliticalCampaignActyInd>
      <LobbyingActivitiesInd>0</LobbyingActivitiesInd>
      <SubjectToProxyTaxInd>0</SubjectToProxyTaxInd>
      <DonorAdvisedFundInd referenceDocumentId="RetDoc1040000001">0</DonorAdvisedFundInd>
      <ConservationEasementsInd referenceDocumentId="RetDoc1040000001">0</ConservationEasementsInd>
      <CollectionsOfArtInd referenceDocumentId="RetDoc1040000001">0</CollectionsOfArtInd>
      <CreditCounselingInd referenceDocumentId="RetDoc1040000001">0</CreditCounselingInd>
      <DonorRstrOrQuasiEndowmentsInd>1</DonorRstrOrQuasiEndowmentsInd>
      <ReportLandBuildingEquipmentInd referenceDocumentId="RetDoc1040000001">1</ReportLandBuildingEquipmentInd>
      <ReportInvestmentsOtherSecInd referenceDocumentId="RetDoc1040000001">0</ReportInvestmentsOtherSecInd>
      <ReportProgramRelatedInvstInd referenceDocumentId="RetDoc1040000001">0</ReportProgramRelatedInvstInd>
      <ReportOtherAssetsInd referenceDocumentId="RetDoc1040000001">0</ReportOtherAssetsInd>
      <ReportOtherLiabilitiesInd referenceDocumentId="RetDoc1040000001">0</ReportOtherLiabilitiesInd>
      <IncludeFIN48FootnoteInd referenceDocumentId="RetDoc1040000001">1</IncludeFIN48FootnoteInd>
      <IndependentAuditFinclStmtInd referenceDocumentId="RetDoc1040000001">1</IndependentAuditFinclStmtInd>
      <ConsolidatedAuditFinclStmtInd referenceDocumentId="RetDoc1040000001">0</ConsolidatedAuditFinclStmtInd>
      <SchoolOperatingInd>0</SchoolOperatingInd>
      <ForeignOfficeInd>0</ForeignOfficeInd>
      <ForeignActivitiesInd referenceDocumentId="RetDoc1040500001">1</ForeignActivitiesInd>
      <MoreThan5000KToOrgInd referenceDocumentId="RetDoc1040500001">1</MoreThan5000KToOrgInd>
      <MoreThan5000KToIndividualsInd referenceDocumentId="RetDoc1040500001">0</MoreThan5000KToIndividualsInd>
      <ProfessionalFundraisingInd referenceDocumentId="RetDoc1041300001">0</ProfessionalFundraisingInd>
      <FundraisingActivitiesInd referenceDocumentId="RetDoc1041300001">1</FundraisingActivitiesInd>
      <GamingActivitiesInd referenceDocumentId="RetDoc1041300001">0</GamingActivitiesInd>
      <OperateHospitalInd>0</OperateHospitalInd>
      <GrantsToOrganizationsInd referenceDocumentId="RetDoc1041900001">1</GrantsToOrganizationsInd>
      <GrantsToIndividualsInd referenceDocumentId="RetDoc1041900001">0</GrantsToIndividualsInd>
      <ScheduleJRequiredInd referenceDocumentId="RetDoc1042400001">1</ScheduleJRequiredInd>
      <TaxExemptBondsInd>0</TaxExemptBondsInd>
      <EngagedInExcessBenefitTransInd>0</EngagedInExcessBenefitTransInd>
      <PYExcessBenefitTransInd>0</PYExcessBenefitTransInd>
      <LoanOutstandingInd>0</LoanOutstandingInd>
      <GrantToRelatedPersonInd>0</GrantToRelatedPersonInd>
      <BusinessRlnWithOrgMemInd>0</BusinessRlnWithOrgMemInd>
      <BusinessRlnWithFamMemInd>0</BusinessRlnWithFamMemInd>
      <BusinessRlnWith35CtrlEntInd>0</BusinessRlnWith35CtrlEntInd>
      <DeductibleNonCashContriInd>0</DeductibleNonCashContriInd>
      <DeductibleArtContributionInd>0</DeductibleArtContributionInd>
      <TerminateOperationsInd>0</TerminateOperationsInd>
      <PartialLiquidationInd>0</PartialLiquidationInd>
      <DisregardedEntityInd>0</DisregardedEntityInd>
      <RelatedEntityInd>0</RelatedEntityInd>
      <RelatedOrganizationCtrlEntInd>0</RelatedOrganizationCtrlEntInd>
      <TrnsfrExmptNonChrtblRltdOrgInd>0</TrnsfrExmptNonChrtblRltdOrgInd>
      <ActivitiesConductedPrtshpInd>0</ActivitiesConductedPrtshpInd>
      <ScheduleORequiredInd>1</ScheduleORequiredInd>
      <IRPDocumentCnt>4</IRPDocumentCnt>
      <IRPDocumentW2GCnt>0</IRPDocumentW2GCnt>
      <BackupWthldComplianceInd>1</BackupWthldComplianceInd>
      <EmployeeCnt>2</EmployeeCnt>
      <EmploymentTaxReturnsFiledInd>1</EmploymentTaxReturnsFiledInd>
      <UnrelatedBusIncmOverLimitInd>0</UnrelatedBusIncmOverLimitInd>
      <ForeignFinancialAccountInd>0</ForeignFinancialAccountInd>
      <ProhibitedTaxShelterTransInd>0</ProhibitedTaxShelterTransInd>
      <TaxablePartyNotificationInd>0</TaxablePartyNotificationInd>
      <NondeductibleContributionsInd>0</NondeductibleContributionsInd>
      <QuidProQuoContributionsInd>1</QuidProQuoContributionsInd>
      <QuidProQuoContriDisclInd>1</QuidProQuoContriDisclInd>
      <Form8282PropertyDisposedOfInd>0</Form8282PropertyDisposedOfInd>
      <RcvFndsToPayPrsnlBnftCntrctInd>0</RcvFndsToPayPrsnlBnftCntrctInd>
      <PayPremiumsPrsnlBnftCntrctInd>0</PayPremiumsPrsnlBnftCntrctInd>
      <IndoorTanningServicesInd>0</IndoorTanningServicesInd>
      <SubjToTaxRmnrtnExPrchtPymtInd>0</SubjToTaxRmnrtnExPrchtPymtInd>
      <SubjectToExcsTaxNetInvstIncInd>0</SubjectToExcsTaxNetInvstIncInd>
      <InfoInScheduleOPartVIInd>X</InfoInScheduleOPartVIInd>
      <GoverningBodyVotingMembersCnt>7</GoverningBodyVotingMembersCnt>
      <IndependentVotingMemberCnt>6</IndependentVotingMemberCnt>
      <FamilyOrBusinessRlnInd>0</FamilyOrBusinessRlnInd>
      <DelegationOfMgmtDutiesInd>0</DelegationOfMgmtDutiesInd>
      <ChangeToOrgDocumentsInd>1</ChangeToOrgDocumentsInd>
      <MaterialDiversionOrMisuseInd>0</MaterialDiversionOrMisuseInd>
      <MembersOrStockholdersInd>0</MembersOrStockholdersInd>
      <ElectionOfBoardMembersInd>0</ElectionOfBoardMembersInd>
      <DecisionsSubjectToApprovaInd>0</DecisionsSubjectToApprovaInd>
      <MinutesOfGoverningBodyInd>1</MinutesOfGoverningBodyInd>
      <MinutesOfCommitteesInd>1</MinutesOfCommitteesInd>
      <OfficerMailingAddressInd>0</OfficerMailingAddressInd>
      <LocalChaptersInd>0</LocalChaptersInd>
      <Form990ProvidedToGvrnBodyInd>1</Form990ProvidedToGvrnBodyInd>
      <ConflictOfInterestPolicyInd>1</ConflictOfInterestPolicyInd>
      <AnnualDisclosureCoveredPrsnInd>1</AnnualDisclosureCoveredPrsnInd>
      <RegularMonitoringEnfrcInd>1</RegularMonitoringEnfrcInd>
      <WhistleblowerPolicyInd>1</WhistleblowerPolicyInd>
      <DocumentRetentionPolicyInd>0</DocumentRetentionPolicyInd>
      <CompensationProcessCEOInd>1</CompensationProcessCEOInd>
      <CompensationProcessOtherInd>1</CompensationProcessOtherInd>
      <InvestmentInJointVentureInd>0</InvestmentInJointVentureInd>
      <StatesWhereCopyOfReturnIsFldCd>CA</StatesWhereCopyOfReturnIsFldCd>
      <UponRequestInd>X</UponRequestInd>
      <BooksInCareOfDetail>
        <BusinessName>
          <BusinessNameLine1Txt>NICOLE MENDEZ-YZAGUIRRE</BusinessNameLine1Txt>
        </BusinessName>
        <PhoneNum>4243584449</PhoneNum>
        <USAddress>
          <AddressLine1Txt>2600 W OLIVE AVE SUITE 500</AddressLine1Txt>
          <CityNm>BURBANK</CityNm>
          <StateAbbreviationCd>CA</StateAbbreviationCd>
          <ZIPCd>91505</ZIPCd>
        </USAddress>
      </BooksInCareOfDetail>
      <Form990PartVIISectionAGrp>
        <PersonNm>JUSTIN DOOLEY</PersonNm>
        <TitleTxt>CHAIRMAN</TitleTxt>
        <AverageHoursPerWeekRt>8.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>50498</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>BIL GALLIO</PersonNm>
        <TitleTxt>SECRETARY</TitleTxt>
        <AverageHoursPerWeekRt>0.15</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>MICHELLE CHAVES</PersonNm>
        <TitleTxt>DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>0.15</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>MELISSA GREGO</PersonNm>
        <TitleTxt>DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>0.15</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>MONICA KIRCHNER</PersonNm>
        <TitleTxt>DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>0.15</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>ENRIQUE LOPEZ</PersonNm>
        <TitleTxt>DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>0.15</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>FRANK M SANCHEZ PHD</PersonNm>
        <TitleTxt>DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>0.15</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>NICOLE MENDEZ</PersonNm>
        <TitleTxt>EXECUTIVE DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>40.00</AverageHoursPerWeekRt>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>182300</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <TotalReportableCompFromOrgAmt>232798</TotalReportableCompFromOrgAmt>
      <TotReportableCompRltdOrgAmt>0</TotReportableCompRltdOrgAmt>
      <TotalOtherCompensationAmt>0</TotalOtherCompensationAmt>
      <IndivRcvdGreaterThan100KCnt>1</IndivRcvdGreaterThan100KCnt>
      <FormerOfcrEmployeesListedInd>0</FormerOfcrEmployeesListedInd>
      <TotalCompGreaterThan150KInd>1</TotalCompGreaterThan150KInd>
      <CompensationFromOtherSrcsInd>0</CompensationFromOtherSrcsInd>
      <ContractorCompensationGrp>
        <ContractorName>
          <BusinessName>
            <BusinessNameLine1Txt>GUSTO PAYROLL</BusinessNameLine1Txt>
          </BusinessName>
        </ContractorName>
        <ContractorAddress>
          <USAddress>
            <AddressLine1Txt>525 20TH ST</AddressLine1Txt>
            <CityNm>SAN FRANCISCO</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>94107</ZIPCd>
          </USAddress>
        </ContractorAddress>
        <ServicesDesc>PAYROLL PROCESSING SERVICES</ServicesDesc>
        <CompensationAmt>259402</CompensationAmt>
      </ContractorCompensationGrp>
      <ContractorCompensationGrp>
        <ContractorName>
          <BusinessName>
            <BusinessNameLine1Txt>MBMEDIA HOLDINGS LLC</BusinessNameLine1Txt>
          </BusinessName>
        </ContractorName>
        <ContractorAddress>
          <USAddress>
            <AddressLine1Txt>700 EAST GARFIELD AVE 101</AddressLine1Txt>
            <CityNm>GLENDALE</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>91205</ZIPCd>
          </USAddress>
        </ContractorAddress>
        <ServicesDesc>MARKETING</ServicesDesc>
        <CompensationAmt>163000</CompensationAmt>
      </ContractorCompensationGrp>
      <CntrctRcvdGreaterThan100KCnt>2</CntrctRcvdGreaterThan100KCnt>
      <FundraisingAmt>132760</FundraisingAmt>
      <AllOtherContributionsAmt>136071</AllOtherContributionsAmt>
      <TotalContributionsAmt>268831</TotalContributionsAmt>
      <InvestmentIncomeGrp>
        <TotalRevenueColumnAmt>473241</TotalRevenueColumnAmt>
        <ExclusionAmt>473241</ExclusionAmt>
      </InvestmentIncomeGrp>
      <GrossAmountSalesAssetsGrp>
        <SecuritiesAmt>1504951</SecuritiesAmt>
      </GrossAmountSalesAssetsGrp>
      <LessCostOthBasisSalesExpnssGrp>
        <SecuritiesAmt>1590420</SecuritiesAmt>
      </LessCostOthBasisSalesExpnssGrp>
      <GainOrLossGrp>
        <SecuritiesAmt>-85469</SecuritiesAmt>
      </GainOrLossGrp>
      <NetGainOrLossInvestmentsGrp>
        <TotalRevenueColumnAmt>-85469</TotalRevenueColumnAmt>
        <ExclusionAmt>-85469</ExclusionAmt>
      </NetGainOrLossInvestmentsGrp>
      <FundraisingGrossIncomeAmt>30204</FundraisingGrossIncomeAmt>
      <ContriRptFundraisingEventAmt>132760</ContriRptFundraisingEventAmt>
      <FundraisingDirectExpensesAmt>394907</FundraisingDirectExpensesAmt>
      <NetIncmFromFundraisingEvtGrp>
        <TotalRevenueColumnAmt>-364703</TotalRevenueColumnAmt>
        <ExclusionAmt>-364703</ExclusionAmt>
      </NetIncmFromFundraisingEvtGrp>
      <TotalRevenueGrp>
        <TotalRevenueColumnAmt>291900</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>0</RelatedOrExemptFuncIncomeAmt>
        <UnrelatedBusinessRevenueAmt>0</UnrelatedBusinessRevenueAmt>
        <ExclusionAmt>23069</ExclusionAmt>
      </TotalRevenueGrp>
      <GrantsToDomesticOrgsGrp>
        <TotalAmt>264513</TotalAmt>
        <ProgramServicesAmt>264513</ProgramServicesAmt>
      </GrantsToDomesticOrgsGrp>
      <ForeignGrantsGrp>
        <TotalAmt>150000</TotalAmt>
        <ProgramServicesAmt>150000</ProgramServicesAmt>
      </ForeignGrantsGrp>
      <CompCurrentOfcrDirectorsGrp>
        <TotalAmt>232798</TotalAmt>
        <ProgramServicesAmt>136725</ProgramServicesAmt>
        <ManagementAndGeneralAmt>50498</ManagementAndGeneralAmt>
        <FundraisingAmt>45575</FundraisingAmt>
      </CompCurrentOfcrDirectorsGrp>
      <OtherSalariesAndWagesGrp>
        <TotalAmt>19086</TotalAmt>
        <ProgramServicesAmt>7890</ProgramServicesAmt>
        <ManagementAndGeneralAmt>8566</ManagementAndGeneralAmt>
        <FundraisingAmt>2630</FundraisingAmt>
      </OtherSalariesAndWagesGrp>
      <OtherEmployeeBenefitsGrp>
        <TotalAmt>1660</TotalAmt>
        <ProgramServicesAmt>953</ProgramServicesAmt>
        <ManagementAndGeneralAmt>389</ManagementAndGeneralAmt>
        <FundraisingAmt>318</FundraisingAmt>
      </OtherEmployeeBenefitsGrp>
      <PayrollTaxesGrp>
        <TotalAmt>16490</TotalAmt>
        <ProgramServicesAmt>9467</ProgramServicesAmt>
        <ManagementAndGeneralAmt>3867</ManagementAndGeneralAmt>
        <FundraisingAmt>3156</FundraisingAmt>
      </PayrollTaxesGrp>
      <FeesForServicesAccountingGrp>
        <TotalAmt>78812</TotalAmt>
        <ManagementAndGeneralAmt>78812</ManagementAndGeneralAmt>
      </FeesForServicesAccountingGrp>
      <FeesForSrvcInvstMgmntFeesGrp>
        <TotalAmt>151256</TotalAmt>
        <ManagementAndGeneralAmt>151256</ManagementAndGeneralAmt>
      </FeesForSrvcInvstMgmntFeesGrp>
      <FeesForServicesOtherGrp>
        <TotalAmt>685</TotalAmt>
        <ProgramServicesAmt>393</ProgramServicesAmt>
        <ManagementAndGeneralAmt>161</ManagementAndGeneralAmt>
        <FundraisingAmt>131</FundraisingAmt>
      </FeesForServicesOtherGrp>
      <AdvertisingGrp>
        <TotalAmt>903</TotalAmt>
        <ProgramServicesAmt>518</ProgramServicesAmt>
        <ManagementAndGeneralAmt>212</ManagementAndGeneralAmt>
        <FundraisingAmt>173</FundraisingAmt>
      </AdvertisingGrp>
      <OfficeExpensesGrp>
        <TotalAmt>25987</TotalAmt>
        <ProgramServicesAmt>14589</ProgramServicesAmt>
        <ManagementAndGeneralAmt>6536</ManagementAndGeneralAmt>
        <FundraisingAmt>4862</FundraisingAmt>
      </OfficeExpensesGrp>
      <OccupancyGrp>
        <TotalAmt>24158</TotalAmt>
        <ProgramServicesAmt>13870</ProgramServicesAmt>
        <ManagementAndGeneralAmt>5665</ManagementAndGeneralAmt>
        <FundraisingAmt>4623</FundraisingAmt>
      </OccupancyGrp>
      <TravelGrp>
        <TotalAmt>376</TotalAmt>
        <ProgramServicesAmt>216</ProgramServicesAmt>
        <ManagementAndGeneralAmt>88</ManagementAndGeneralAmt>
        <FundraisingAmt>72</FundraisingAmt>
      </TravelGrp>
      <DepreciationDepletionGrp>
        <TotalAmt>3658</TotalAmt>
        <ManagementAndGeneralAmt>3658</ManagementAndGeneralAmt>
      </DepreciationDepletionGrp>
      <InsuranceGrp>
        <TotalAmt>17796</TotalAmt>
        <ProgramServicesAmt>10217</ProgramServicesAmt>
        <ManagementAndGeneralAmt>4173</ManagementAndGeneralAmt>
        <FundraisingAmt>3406</FundraisingAmt>
      </InsuranceGrp>
      <OtherExpensesGrp>
        <Desc>LINKED BY LOVE PROGRAM</Desc>
        <TotalAmt>17812</TotalAmt>
        <ProgramServicesAmt>17812</ProgramServicesAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>EDUCATION EXPENSES</Desc>
        <TotalAmt>5473</TotalAmt>
        <ProgramServicesAmt>5473</ProgramServicesAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>GIFTS</Desc>
        <TotalAmt>4001</TotalAmt>
        <ProgramServicesAmt>2297</ProgramServicesAmt>
        <ManagementAndGeneralAmt>938</ManagementAndGeneralAmt>
        <FundraisingAmt>766</FundraisingAmt>
      </OtherExpensesGrp>
      <TotalFunctionalExpensesGrp>
        <TotalAmt>1015464</TotalAmt>
        <ProgramServicesAmt>634933</ProgramServicesAmt>
        <ManagementAndGeneralAmt>314819</ManagementAndGeneralAmt>
        <FundraisingAmt>65712</FundraisingAmt>
      </TotalFunctionalExpensesGrp>
      <CashNonInterestBearingGrp>
        <BOYAmt>1121083</BOYAmt>
        <EOYAmt>1254577</EOYAmt>
      </CashNonInterestBearingGrp>
      <SavingsAndTempCashInvstGrp>
        <BOYAmt>68443</BOYAmt>
        <EOYAmt>149832</EOYAmt>
      </SavingsAndTempCashInvstGrp>
      <PledgesAndGrantsReceivableGrp>
        <BOYAmt>353948</BOYAmt>
        <EOYAmt>340895</EOYAmt>
      </PledgesAndGrantsReceivableGrp>
      <PrepaidExpensesDefrdChargesGrp>
        <BOYAmt>49057</BOYAmt>
        <EOYAmt>5920</EOYAmt>
      </PrepaidExpensesDefrdChargesGrp>
      <LandBldgEquipCostOrOtherBssAmt>83615</LandBldgEquipCostOrOtherBssAmt>
      <LandBldgEquipAccumDeprecAmt>68263</LandBldgEquipAccumDeprecAmt>
      <LandBldgEquipBasisNetGrp>
        <BOYAmt>19010</BOYAmt>
        <EOYAmt>15352</EOYAmt>
      </LandBldgEquipBasisNetGrp>
      <InvestmentsPubTradedSecGrp>
        <BOYAmt>14836388</BOYAmt>
        <EOYAmt>15812627</EOYAmt>
      </InvestmentsPubTradedSecGrp>
      <TotalAssetsGrp>
        <BOYAmt>16447929</BOYAmt>
        <EOYAmt>17579203</EOYAmt>
      </TotalAssetsGrp>
      <AccountsPayableAccrExpnssGrp>
        <BOYAmt>117222</BOYAmt>
        <EOYAmt>31965</EOYAmt>
      </AccountsPayableAccrExpnssGrp>
      <GrantsPayableGrp>
        <BOYAmt>299564</BOYAmt>
        <EOYAmt>475741</EOYAmt>
      </GrantsPayableGrp>
      <TotalLiabilitiesGrp>
        <BOYAmt>416786</BOYAmt>
        <EOYAmt>507706</EOYAmt>
      </TotalLiabilitiesGrp>
      <OrganizationFollowsFASB117Ind>X</OrganizationFollowsFASB117Ind>
      <NoDonorRestrictionNetAssetsGrp>
        <BOYAmt>5841736</BOYAmt>
        <EOYAmt>6235435</EOYAmt>
      </NoDonorRestrictionNetAssetsGrp>
      <DonorRestrictionNetAssetsGrp>
        <BOYAmt>10189407</BOYAmt>
        <EOYAmt>10836062</EOYAmt>
      </DonorRestrictionNetAssetsGrp>
      <TotalNetAssetsFundBalanceGrp>
        <BOYAmt>16031143</BOYAmt>
        <EOYAmt>17071497</EOYAmt>
      </TotalNetAssetsFundBalanceGrp>
      <TotLiabNetAssetsFundBalanceGrp>
        <BOYAmt>16447929</BOYAmt>
        <EOYAmt>17579203</EOYAmt>
      </TotLiabNetAssetsFundBalanceGrp>
      <ReconcilationRevenueExpnssAmt>-723564</ReconcilationRevenueExpnssAmt>
      <NetUnrlzdGainsLossesInvstAmt>1763918</NetUnrlzdGainsLossesInvstAmt>
      <OtherChangesInNetAssetsAmt>0</OtherChangesInNetAssetsAmt>
      <MethodOfAccountingAccrualInd>X</MethodOfAccountingAccrualInd>
      <AccountantCompileOrReviewInd>0</AccountantCompileOrReviewInd>
      <FSAuditedInd>1</FSAuditedInd>
      <FSAuditedBasisGrp>
        <SeparateBasisFinclStmtInd>X</SeparateBasisFinclStmtInd>
      </FSAuditedBasisGrp>
      <AuditCommitteeInd>1</AuditCommitteeInd>
      <FederalGrantAuditRequiredInd>0</FederalGrantAuditRequiredInd>
    </IRS990>
    <IRS990ScheduleA documentId="RetDoc1039100001">
      <PublicOrganization170Ind>X</PublicOrganization170Ind>
      <GiftsGrantsContriRcvd170Grp>
        <CurrentTaxYearMinus4YearsAmt>480306</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>325083</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>507290</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>211917</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>268831</CurrentTaxYearAmt>
        <TotalAmt>1793427</TotalAmt>
      </GiftsGrantsContriRcvd170Grp>
      <TotalCalendarYear170Grp>
        <CurrentTaxYearMinus4YearsAmt>480306</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>325083</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>507290</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>211917</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>268831</CurrentTaxYearAmt>
        <TotalAmt>1793427</TotalAmt>
      </TotalCalendarYear170Grp>
      <SubstantialContributorsTotAmt>446779</SubstantialContributorsTotAmt>
      <PublicSupportTotal170Amt>1346648</PublicSupportTotal170Amt>
      <GrossInvestmentIncome170Grp>
        <CurrentTaxYearMinus4YearsAmt>344448</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>354189</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>252818</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>357150</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>473241</CurrentTaxYearAmt>
        <TotalAmt>1781846</TotalAmt>
      </GrossInvestmentIncome170Grp>
      <TotalSupportAmt>3575273</TotalSupportAmt>
      <PublicSupportCY170Pct>0.37670</PublicSupportCY170Pct>
      <PublicSupportPY170Pct>0.38730</PublicSupportPY170Pct>
      <ThirtyThrPctSuprtTestsCY170Ind>X</ThirtyThrPctSuprtTestsCY170Ind>
    </IRS990ScheduleA>
    <IRS990ScheduleB documentId="RetDoc1234500001">
      <ContributorInformationGrp>
        <ContributorNum>RESTRICTED</ContributorNum>
        <ContributorBusinessName>
          <BusinessNameLine1>RESTRICTED</BusinessNameLine1>
        </ContributorBusinessName>
        <ContributorUSAddress>
          <AddressLine1>RESTRICTED</AddressLine1>
          <AddressLine2>RESTRICTED</AddressLine2>
          <City>RESTRICTED</City>
          <State>RESTRICTED</State>
          <ZIPCode>RESTRICTED</ZIPCode>
        </ContributorUSAddress>
        <TotalContributionsAmt>RESTRICTED</TotalContributionsAmt>
      </ContributorInformationGrp>
    </IRS990ScheduleB>
    <IRS990ScheduleD documentId="RetDoc1040000001">
      <CYEndwmtFundGrp>
        <BeginningYearBalanceAmt>4746728</BeginningYearBalanceAmt>
        <InvestmentEarningsOrLossesAmt>586691</InvestmentEarningsOrLossesAmt>
        <OtherExpendituresAmt>114513</OtherExpendituresAmt>
        <EndYearBalanceAmt>5218906</EndYearBalanceAmt>
      </CYEndwmtFundGrp>
      <CYMinus1YrEndwmtFundGrp>
        <BeginningYearBalanceAmt>5906597</BeginningYearBalanceAmt>
        <InvestmentEarningsOrLossesAmt>-860869</InvestmentEarningsOrLossesAmt>
        <OtherExpendituresAmt>299000</OtherExpendituresAmt>
        <EndYearBalanceAmt>4746728</EndYearBalanceAmt>
      </CYMinus1YrEndwmtFundGrp>
      <CYMinus2YrEndwmtFundGrp>
        <BeginningYearBalanceAmt>5450465</BeginningYearBalanceAmt>
        <InvestmentEarningsOrLossesAmt>506132</InvestmentEarningsOrLossesAmt>
        <OtherExpendituresAmt>50000</OtherExpendituresAmt>
        <EndYearBalanceAmt>5906597</EndYearBalanceAmt>
      </CYMinus2YrEndwmtFundGrp>
      <CYMinus3YrEndwmtFundGrp>
        <BeginningYearBalanceAmt>5009603</BeginningYearBalanceAmt>
        <InvestmentEarningsOrLossesAmt>590223</InvestmentEarningsOrLossesAmt>
        <OtherExpendituresAmt>149361</OtherExpendituresAmt>
        <EndYearBalanceAmt>5450465</EndYearBalanceAmt>
      </CYMinus3YrEndwmtFundGrp>
      <CYMinus4YrEndwmtFundGrp>
        <BeginningYearBalanceAmt>4334591</BeginningYearBalanceAmt>
        <InvestmentEarningsOrLossesAmt>675012</InvestmentEarningsOrLossesAmt>
        <EndYearBalanceAmt>5009603</EndYearBalanceAmt>
      </CYMinus4YrEndwmtFundGrp>
      <BoardDesignatedBalanceEOYPct>0.00000</BoardDesignatedBalanceEOYPct>
      <PrmnntEndowmentBalanceEOYPct>0.72812</PrmnntEndowmentBalanceEOYPct>
      <TermEndowmentBalanceEOYPct>0.27188</TermEndowmentBalanceEOYPct>
      <EndowmentsHeldUnrelatedOrgInd>0</EndowmentsHeldUnrelatedOrgInd>
      <EndowmentsHeldRelatedOrgInd>0</EndowmentsHeldRelatedOrgInd>
      <EquipmentGrp>
        <OtherCostOrOtherBasisAmt>83615</OtherCostOrOtherBasisAmt>
        <DepreciationAmt>68263</DepreciationAmt>
        <BookValueAmt>15352</BookValueAmt>
      </EquipmentGrp>
      <TotalBookValueLandBuildingsAmt>15352</TotalBookValueLandBuildingsAmt>
      <FootnoteTextInd>X</FootnoteTextInd>
      <TotalRevEtcAuditedFinclStmtAmt>2299469</TotalRevEtcAuditedFinclStmtAmt>
      <NetUnrealizedGainsInvstAmt>1763918</NetUnrealizedGainsInvstAmt>
      <RevenueNotReportedAmt>1763918</RevenueNotReportedAmt>
      <RevenueSubtotalAmt>535551</RevenueSubtotalAmt>
      <InvestmentExpensesNotIncldAmt>151256</InvestmentExpensesNotIncldAmt>
      <OtherRevenuesNotIncludedAmt>-394907</OtherRevenuesNotIncludedAmt>
      <RevenueNotReportedFinclStmtAmt>-243651</RevenueNotReportedFinclStmtAmt>
      <TotalRevenuePerForm990Amt>291900</TotalRevenuePerForm990Amt>
      <TotExpnsEtcAuditedFinclStmtAmt>1259115</TotExpnsEtcAuditedFinclStmtAmt>
      <OtherExpensesIncludedAmt>394907</OtherExpensesIncludedAmt>
      <ExpensesNotReportedAmt>394907</ExpensesNotReportedAmt>
      <ExpensesSubtotalAmt>864208</ExpensesSubtotalAmt>
      <InvestmentExpensesNotIncld2Amt>151256</InvestmentExpensesNotIncld2Amt>
      <ExpensesNotRptFinclStmtAmt>151256</ExpensesNotRptFinclStmtAmt>
      <TotalExpensesPerForm990Amt>1015464</TotalExpensesPerForm990Amt>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART V, LINE 4:</FormAndLineReferenceDesc>
        <ExplanationTxt>INTENDED USE OF THE ENDOWMENT FUNDS ARE FOR RESEARCH AND EDUCATION PURPOSES.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART X, LINE 2:</FormAndLineReferenceDesc>
        <ExplanationTxt>ACCOUNTING PRINCIPLES GENERALLY ACCEPTED IN THE UNITED STATES OF AMERICA REQUIRE MANAGEMENT TO EVALUATE TAX POSITIONS TAKEN BY THE FOUNDATION AND RECOGNIZE A TAX LIABILITY (OR ASSET) IF THE FOUNDATION HAS TAKEN AN UNCERTAIN POSITION THAT MORE LIKELY THAN NOT WOULD NOT BE SUSTAINED UPON EXAMINATION BY THE INTERNAL REVENUE SERVICE. MANAGEMENT HAS ANALYZED THE TAX POSITIONS TAKEN BY THE FOUNDATION, AND HAS CONCLUDED THAT AS OF DECEMBER 31, 2023 AND 2022, THERE ARE NO UNCERTAIN POSITIONS TAKEN OR EXPECTED TO BE TAKEN THAT WOULD REQUIRE RECOGNITION OF A LIABILITY (OR ASSET) OR DISCLOSURE IN THE FINANCIAL STATEMENTS. THE FOUNDATION IS SUBJECT TO ROUTINE AUDITS BY TAXING JURISDICTIONS; HOWEVER, THERE ARE CURRENTLY NO AUDITS FOR ANY TAX PERIOD IN PROGRESS. MANAGEMENT BELIEVES IT IS NO LONGER SUBJECT TO INCOME TAX EXAMINATIONS FOR YEARS PRIOR TO 2020.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART XI, LINE 4B - OTHER ADJUSTMENTS:</FormAndLineReferenceDesc>
        <ExplanationTxt>DIRECT FUNDRAISING EXPENSES -394,907.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART XII, LINE 2D - OTHER ADJUSTMENTS:</FormAndLineReferenceDesc>
        <ExplanationTxt>DIRECT FUNDRAISING EXPENSES 394,907.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleD>
    <IRS990ScheduleF documentId="RetDoc1040500001">
      <GrantRecordsMaintainedInd>1</GrantRecordsMaintainedInd>
      <AccountActivitiesOutsideUSGrp>
        <RegionTxt>NORTH AMERICA - CANADA AND MEXICO, BUT NOT THE UNITED STATES</RegionTxt>
        <OfficesCnt>0</OfficesCnt>
        <EmployeeCnt>0</EmployeeCnt>
        <TypeOfActivitiesConductedTxt>RESEARCH GRANT TO ADVANCE THE SCIENCE AND PRACTICE OF ORGAN TRANSPLANTATION.</TypeOfActivitiesConductedTxt>
        <RegionTotalExpendituresAmt>150000</RegionTotalExpendituresAmt>
      </AccountActivitiesOutsideUSGrp>
      <SubtotalOfficesCnt>0</SubtotalOfficesCnt>
      <SubtotalEmployeesCnt>0</SubtotalEmployeesCnt>
      <ContinuationTotalOfficeCnt>0</ContinuationTotalOfficeCnt>
      <ContinuationTotalEmployeeCnt>0</ContinuationTotalEmployeeCnt>
      <TotalOfficeCnt>0</TotalOfficeCnt>
      <TotalEmployeeCnt>0</TotalEmployeeCnt>
      <SubtotalSpentAmt>150000</SubtotalSpentAmt>
      <ContinuationSpentAmt>0</ContinuationSpentAmt>
      <TotalSpentAmt>150000</TotalSpentAmt>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>NORTH AMERICA - CANADA AND MEXICO, BUT NOT THE UNITED STATES</RegionTxt>
        <PurposeOfGrantTxt>RESEARCH GRANT TO ADVANCE THE SCIENCE AND PRACTICE OF ORGAN TRANSPLANTATION.</PurposeOfGrantTxt>
        <CashGrantAmt>150000</CashGrantAmt>
        <MannerOfCashDisbursementTxt>WIRE TRANSFER</MannerOfCashDisbursementTxt>
        <NonCashAssistanceAmt>0</NonCashAssistanceAmt>
      </GrantsToOrgOutsideUSGrp>
      <Total501c3OrgCnt>1</Total501c3OrgCnt>
      <TotalOtherOrgCnt>0</TotalOtherOrgCnt>
      <TransferToForeignCorpInd>0</TransferToForeignCorpInd>
      <InterestInForeignTrustInd>0</InterestInForeignTrustInd>
      <ForeignCorpOwnershipInd>0</ForeignCorpOwnershipInd>
      <PassiveForeignInvestmestCoInd>0</PassiveForeignInvestmestCoInd>
      <ForeignPartnershipInd>0</ForeignPartnershipInd>
      <BoycottCountriesInd>0</BoycottCountriesInd>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART I, LINE 2:</FormAndLineReferenceDesc>
        <ExplanationTxt>THE GRANTEES ARE REQUIRED TO COMPLETE A FINAL REPORT AT THE END OF THE GRANT PERIOD WHICH INCLUDES: EXPLANATION OF COMPLETING THE AIMS/GOALS, DATA/OUTCOMES, AND FINAL BUDGET. DEPENDING UPON THE AMOUNT AND DURATION OF THE GRANT, FOR EXAMPLE 2-YEAR GRANTS, GRANTEES MAY BE REQUIRED TO SUBMIT A PROGRESS REPORT PRIOR TO RELEASING A SECOND INSTALLMENT OF FUNDS. THE RESEARCH ADVISORY BOARD REVIEWS AND EVALUATES PROGRESS AND FINAL REPORTS.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleF>
    <IRS990ScheduleG documentId="RetDoc1041300001">
      <FundraisingEventInformationGrp>
        <Event1Nm>LINKED BY LOVE PREMIERE &amp; GALA</Event1Nm>
        <GrossReceiptsEvent1Amt>162400</GrossReceiptsEvent1Amt>
        <CharitableContriEvent1Amt>132760</CharitableContriEvent1Amt>
        <GrossRevenueEvent1Amt>29640</GrossRevenueEvent1Amt>
        <RentFacilityCostsEvent1Amt>18575</RentFacilityCostsEvent1Amt>
        <FoodAndBeverageEvent1Amt>1318</FoodAndBeverageEvent1Amt>
        <OtherDirectExpensesEvent1Amt>660622</OtherDirectExpensesEvent1Amt>
        <Event2Nm>ROCK &amp; RAISE</Event2Nm>
        <GrossReceiptsEvent2Amt>564</GrossReceiptsEvent2Amt>
        <GrossRevenueEvent2Amt>564</GrossRevenueEvent2Amt>
        <OtherDirectExpensesEvent2Amt>12</OtherDirectExpensesEvent2Amt>
        <GrossReceiptsTotalAmt>162964</GrossReceiptsTotalAmt>
        <CharitableContributionsTotAmt>132760</CharitableContributionsTotAmt>
        <GrossRevenueTotalEventsAmt>30204</GrossRevenueTotalEventsAmt>
        <RentFcltyCostsTotalEventsAmt>18575</RentFcltyCostsTotalEventsAmt>
        <FoodAndBeverageTotalEventsAmt>1318</FoodAndBeverageTotalEventsAmt>
        <OthDirectExpnssTotalEventsAmt>660634</OthDirectExpnssTotalEventsAmt>
        <DirectExpenseSummaryEventsAmt>680527</DirectExpenseSummaryEventsAmt>
        <NetIncomeSummaryAmt>-650323</NetIncomeSummaryAmt>
      </FundraisingEventInformationGrp>
    </IRS990ScheduleG>
    <IRS990ScheduleI documentId="RetDoc1041900001">
      <GrantRecordsMaintainedInd>1</GrantRecordsMaintainedInd>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>MAYO CLINIC</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>200 FIRST STREET SW</AddressLine1Txt>
          <CityNm>ROCHESTER</CityNm>
          <StateAbbreviationCd>MN</StateAbbreviationCd>
          <ZIPCd>55905</ZIPCd>
        </USAddress>
        <RecipientEIN>416011702</RecipientEIN>
        <IRCSectionDesc>501(C)(3)</IRCSectionDesc>
        <CashGrantAmt>114513</CashGrantAmt>
        <NonCashAssistanceAmt>0</NonCashAssistanceAmt>
        <PurposeOfGrantTxt>RESEARCH TO ADVANCE THE SCIENCE AND PRACTICE OF ORGAN TRANSPLANTATION</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>BRIGAM &amp; WOMEN'S HOSPITAL</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>75 FRANCIS STREET</AddressLine1Txt>
          <CityNm>BOSTON</CityNm>
          <StateAbbreviationCd>MA</StateAbbreviationCd>
          <ZIPCd>02115</ZIPCd>
        </USAddress>
        <RecipientEIN>042312909</RecipientEIN>
        <IRCSectionDesc>501(C)(3)</IRCSectionDesc>
        <CashGrantAmt>150000</CashGrantAmt>
        <NonCashAssistanceAmt>0</NonCashAssistanceAmt>
        <PurposeOfGrantTxt>RESEARCH TO ADVANCE THE SCIENCE AND PRACTICE OF ORGAN TRANSPLANTATION</PurposeOfGrantTxt>
      </RecipientTable>
      <Total501c3OrgCnt>2</Total501c3OrgCnt>
      <TotalOtherOrgCnt>0</TotalOtherOrgCnt>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART I, LINE 2:</FormAndLineReferenceDesc>
        <ExplanationTxt>THE GRANTEES ARE REQUIRED TO COMPLETE A FINAL REPORT AT THE END OF THE GRANT PERIOD WHICH INCLUDES: EXPLANATION OF COMPLETING THE AIMS/GOALS, DATA/OUTCOMES, AND FINAL BUDGET. DEPENDING UPON THE AMOUNT AND DURATION OF THE GRANT, FOR EXAMPLE 2-YEAR GRANTS, GRANTEES MAY BE REQUIRED TO SUBMIT A PROGRESS REPORT PRIOR TO RELEASING A SECOND INSTALLMENT OF FUNDS. THE RESEARCH ADVISORY BOARD REVIEWS AND EVALUATES PROGRESS AND FINAL REPORTS.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleI>
    <IRS990ScheduleJ documentId="RetDoc1042400001">
      <Form990OfOtherOrganizationsInd>X</Form990OfOtherOrganizationsInd>
      <BoardOrCommitteeApprovalInd>X</BoardOrCommitteeApprovalInd>
      <SeverancePaymentInd>0</SeverancePaymentInd>
      <SupplementalNonqualRtrPlanInd>0</SupplementalNonqualRtrPlanInd>
      <EquityBasedCompArrngmInd>0</EquityBasedCompArrngmInd>
      <CompBasedOnRevenueOfFlngOrgInd>0</CompBasedOnRevenueOfFlngOrgInd>
      <CompBsdOnRevRelatedOrgsInd>0</CompBsdOnRevRelatedOrgsInd>
      <CompBsdNetEarnsFlngOrgInd>0</CompBsdNetEarnsFlngOrgInd>
      <CompBsdNetEarnsRltdOrgsInd>0</CompBsdNetEarnsRltdOrgsInd>
      <AnyNonFixedPaymentsInd>0</AnyNonFixedPaymentsInd>
      <InitialContractExceptionInd>0</InitialContractExceptionInd>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>NICOLE MENDEZ</PersonNm>
        <TitleTxt>EXECUTIVE DIRECTOR</TitleTxt>
        <BaseCompensationFilingOrgAmt>182300</BaseCompensationFilingOrgAmt>
        <CompensationBasedOnRltdOrgsAmt>0</CompensationBasedOnRltdOrgsAmt>
        <BonusFilingOrganizationAmount>0</BonusFilingOrganizationAmount>
        <BonusRelatedOrganizationsAmt>0</BonusRelatedOrganizationsAmt>
        <OtherCompensationFilingOrgAmt>0</OtherCompensationFilingOrgAmt>
        <OtherCompensationRltdOrgsAmt>0</OtherCompensationRltdOrgsAmt>
        <DeferredCompensationFlngOrgAmt>0</DeferredCompensationFlngOrgAmt>
        <DeferredCompRltdOrgsAmt>0</DeferredCompRltdOrgsAmt>
        <NontaxableBenefitsFilingOrgAmt>0</NontaxableBenefitsFilingOrgAmt>
        <NontaxableBenefitsRltdOrgsAmt>0</NontaxableBenefitsRltdOrgsAmt>
        <TotalCompensationFilingOrgAmt>182300</TotalCompensationFilingOrgAmt>
        <TotalCompensationRltdOrgsAmt>0</TotalCompensationRltdOrgsAmt>
        <CompReportPrior990FilingOrgAmt>0</CompReportPrior990FilingOrgAmt>
        <CompReportPrior990RltdOrgsAmt>0</CompReportPrior990RltdOrgsAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
    </IRS990ScheduleJ>
    <IRS990ScheduleO documentId="RetDoc1044400001">
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART III, LINE 2</FormAndLineReferenceDesc>
        <ExplanationTxt>RESEARCH GRANT PROGRAM: THE NITF AWARDS RESEARCH GRANTS SEMIANNUALLY TO IMPROVE CLINICAL OUTCOMES AND POSITIVELY IMPACT THE FIELD OF TRANSPLANTATION. IN 2023, NITF AWARDED 3 GRANTS TOTALING $414,513. BROADCAST AND SOCIAL MEDIA CAMPAIGNS: IN 2023, NITF RELEASED THE LINKED BY LOVE PSA ON TV AND RADIO TO INCREASE AWARENESS ABOUT KIDNEY DISEASE AND FAILURE, TRANSPLANTATION AND LIVING DONATION. THERE WAS ABOUT 205,500,000 IMPRESSIONS (TRACKED FROM FEB. THROUGH JULY 2023). THE SOCIAL MEDIA CAMPAIGN PROVIDED KIDNEY DISEASE PREVENTION,HEALTHY LIVING, KIDNEY TRANSPLANT AND LIVING DONATION INFORMATION BY POSTING ON FACEBOOK, INSTAGRAM AND TIKTOK. THERE WERE OVER 1,190,000 IMPRESSIONS. BOTH CAMPAIGNS TARGETED THE BLACK AND HISPANIC POPULATIONS, WHO ARE MOST AT-RISK OF KIDNEY DISEASE AND FAILURE IN AN EFFORT TO DECREASE THE DISPARITIES.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION A, LINE 4</FormAndLineReferenceDesc>
        <ExplanationTxt>A CONFLICT OF INTEREST POLICY HAS BEEN INSTATED DURING THE YEAR. THE CONFLICT OF INTEREST POLICY INCLUDES THE FOLLOWING PROCEDURES: THE DUTY TO DISCLOSE THE EXISTENCE OF THE FINANCIAL INTEREST AND BE GIVEN THE OPPORTUNITY TO DISCLOSE ALL MATERIAL FACTS TO THE DIRECTORS AND MEMBERS OF COMMITTEES; DETERMING WHETHER A CONFLICT OF INTEREST EXISTS AFTER ALL INFORMATION IS PRESENTED AT THE BOARD OR COMMITTEE MEETING, WHICH IS THEN VOTED ON; IF THERE IS REASONABLE CAUSE TO BELIEAVE A MEMBER HAS FAILED TO DISCLOSE AN ACTUAL OR POSSIBLE CONFLICT OF INTEREST, AN INVESTIGATION WILL TAKE PLACE AND DISCIPLINARY AND CORRECTIVE ACTION MAY OCCUR. APPLICABLE INDIVIDUALS MUST SIGN A CONFLICT OF INTEREST DISCLOSURE STATEMENT.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION B, LINE 11B</FormAndLineReferenceDesc>
        <ExplanationTxt>A COPY OF THE FORM 990 AND ALL APPLICABLE SCHEDULES ARE PROVIDED TO THE AUDIT COMMITTEE MEMBERS OF THE BOARD OF DIRECTORS PRIOR TO FILING THE RETURN.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION B, LINE 12C</FormAndLineReferenceDesc>
        <ExplanationTxt>THE ORGANIZATION'S CONFLICT OF INTEREST POLICY IS CONSISTENTLY AND REGULARLY ENFORCED. TO ENSURE THE ORGANIZATION OPERATES IN A MANNER CONSISTENT WITH ITS CHARITABLE PURPOSE, PERIODIC REVIEWS WILL BE CONDUCTED TO DETERMINE WHETHER COMPENSATION AND BENEFITS ARE REASONABLE AND WHETHER PARTNERSHIPS, JOINT VENTURES, AND ARRANGEMENTS WITH MANAGEMENT ORGANIZATIONS CONFORM TO THE ORGANIZATION'S WRITTEN POLICIES. APPLICABLE INDIVIDUALS MUST SIGN A CONFLICT OF INTEREST DISCLOSURE STATEMENT.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION B, LINE 15</FormAndLineReferenceDesc>
        <ExplanationTxt>THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS REVIEWS AND APPROVES THE EXECUTIVE DIRECTOR AND CHAIRMAN'S COMPENSATION. THE COMMITTEE USES COMPARABLE MARKET DATA FOR NON-PROFIT EXECUTIVE POSITIONS WHEN DETERMINING COMPENSATION.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION C, LINE 19</FormAndLineReferenceDesc>
        <ExplanationTxt>THE ORGANIZATION'S GOVERNING DOCUMENTS AND AUDITED FINANCIAL STATEMENTS ARE AVAILABLE TO THE PUBLIC UPON REQUEST. WHILE THE ORGANIZATION DOES NOT HAVE A WRITTEN CONFLICT OF INTEREST POLICY, THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS REVIEWS AND APPROVES ANY AND ALL RELATED PARTY TRANSACTIONS AND DOCUMENTS SUCH REVIEW IN CONTEMPORANEOUS WRITTEN AND APPROVED MINUTES.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleO>
  </ReturnData>
</Return>